Remove Layoffs Remove Product Remove San Diego Remove Technical Review
article thumbnail

Qualcomm: No Changes After Strategic Review

socalTECH

San Diego-based Qualcomm says that its board of directors has decided to stay the course, and will make no change to the company's corporate and financial structure, after a strategic review by a special committee of its board.

article thumbnail

Biotech Roundup: Moonshots, Pink Slips, Gilead, Brexit & More

Xconomy

At the gathering, Biden took verbal shots at scofflaw cancer researchers and at drug prices, while the FDA said it would take a shot at restructuring the way it evaluates oncology products. The technology was funded by the Department of Defense and comes from MIT’s Lincoln Lab. It also got a pat on the back from Bill Gates. .

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Biotech Roundup: Hellos, Goodbyes, “Cures” Delays And Trial News

Xconomy

Our San Diego editor Bruce Bigelow penned a personal goodbye to entrepreneur Larry Bock, who died last week of pancreatic cancer at the age of 56. All eyes are on Holmes, who is scheduled to present data from the company’s technology at a medical conference on August 1. The week started on a reflective note.

News 40
article thumbnail

Biotech Roundup: Kadmon Debt, Hemo Data, Loose Lips & More

Xconomy

Despite technical differences and the early nature of the data that made comparison difficult, Wall Street declared Spark this week’s winner. —The FDA approved a cholera vaccine , Vaxchora, giving Redwood City, CA-based PaxVax its second commercial product. UniQure’s shares fell more than 16 percent. right now. .

News 55